Our in-depth analysis has emphasized the central importance of insulin resistance and metabolic disturbances in the pathogenesis of DCM, shedding light on the complex interplay between insulin signaling genes and cardiac dysfunction. The gene discussed is INS; the disease is familial dilated cardiomyopathy.